Stephanie Kennan on Medicare Advantage

Washington Healthcare Update - October 2023 #4

This Week in Washington: Still No Speaker in the House; NIH Director Nominee has Hearing; FDA Seeking Feedback on Innovative Drug Clinical Trial Design....more

10/24/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare Advantage , OCR , Proposed Rules

Washington Healthcare Update - May 2023 #2

This Week in Washington: Debt Ceiling Continues to Loom Over the Capitol; DEA Extends COVID-19 Controlled Medications Prescribing Telehealth Flexibilities...more

5/16/2023 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare Advantage , Medicare Part D , OCR , Popular , Proposed Rules , Public Health Emergency , Telemedicine

Washington Healthcare Update - May 2023

This Week in Washington: Debt Limit fight continues; Disagreements arise during Senate HELP Committee mark-up of PBM and Generic Drug Competition Bills...more

5/9/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , GAO , HRSA , Medicare , Medicare Advantage , Popular , Proposed Rules

Washington Healthcare Update - April 2023 #2

This Week in Washington: CMS Releases Annual Payment Rules for Skilled Nursing Facilities, Hospice and Other Segments of Medicare...more

4/11/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , Medicare , Medicare Advantage , Proposed Rules , SAMHSA

President Biden’s Budget Invests in Healthcare

Although President Biden’s budget is almost always dead on arrival on Capitol Hill, it serves as an outline of the administration’s priorities. In the budget process, the House and Senate are to work separately on budget...more

3/14/2023 / Affordable Care Act , Biden Administration , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Federal Budget , Food and Drug Administration (FDA) , Medicare , Medicare Advantage , Prescription Drugs , Telehealth

Washington Healthcare Update - November 2022

This Week in Washington: Congress returns to complete appropriations and year-end legislation....more

11/22/2022 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare Advantage , Popular , Proposed Rules

Washington Healthcare Update - January 2022 #4

This Week in Washington: Senate HELP Committee Chair Patty Murray and Ranking Member Richard Burr Release Discussion Draft of Bipartisan Pandemic and Public Health Response Bill....more

2/1/2022 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Durable Medical Equipment , Final Rules , Food and Drug Administration (FDA) , GAO , HRSA , Medical Devices , Medicare , Medicare Advantage , Medicare Part D , Proposed Rules

Omnibus Appropriations Package Includes Changes for Medicare and Medicaid Beneficiaries

Passed by Congress Dec. 21, 2020, and signed by President Donald Trump Dec. 27, 2020, the $1.4 trillion omnibus Consolidated Appropriations Act includes numerous provisions that directly impact Medicare and Medicaid...more

1/7/2021 / Centers for Medicare & Medicaid Services (CMS) , Consolidated Appropriations Act (CAA) , Department of Health and Human Services (HHS) , Medicaid , Medicare , Medicare Advantage , Medicare Part A , Medicare Part D

Washington Healthcare Update - March 2020 #2

This week in Washington: CMS develops additional code for coronavirus lab tests, announces actions to address spread of coronavirus; House passes bill to ban e-cigarette flavors; Grassley says updated Senate Finance drug...more

3/10/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , E-Cigarettes , Food and Drug Administration (FDA) , GAO , Medicare Advantage , Medicare Part D , Pharmaceutical Industry

Washington Healthcare Update - March 2020 #1

This week in Washington: Hearings scheduled on the U.S. response to the Coronavirus. ...more

3/3/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicaid , Medicare , Medicare Advantage , Pharmaceutical Industry

Washington Healthcare Update - February 2020 #4

Upcoming Hearings/Markups - Wednesday, February 26, 2020 - House Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies: “Department of Health and Human Services...more

2/25/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Medicare , Medicare Advantage , Medicare Part D , Prescription Drugs

Washington Healthcare Update - February 2020 #3

This week in Washington: The House and Senate will be in recess the week of Feb. 17 in observation of Presidents Day....more

2/18/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicaid , Medicare , Medicare Advantage , Medicare Part D , Trump Administration

Washington Healthcare Update - February 2020 #1

This week in Washington: The House of Representatives passes legislation on fentanyl analogues; Senate continues impeachment trial....more

2/4/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicare Advantage , Trump Administration

Washington Healthcare Update - January 2020 #3

This week in Washington: The House is not in session. The Senate will resume the impeachment trial on Tuesday....more

1/22/2020 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Drug Pricing , Food and Drug Administration (FDA) , HRSA , MACPAC , Medicare , Medicare Advantage , Pharmaceutical Industry , Trump Administration , United States-Mexico-Canada Agreement (USMCA)

Supreme Court Rules HHS Cannot Take Short-Cuts in Rulemaking

In a 7-to-1 decision, the U.S. Supreme Court on June 3, 2019, held that “Because the Department of Health and Human Services neglected its statutory notice-and-comment obligations when it revealed a new policy that...more

6/11/2019 / Administrative Procedure Act , Azar v Allina Health Services , Department of Health and Human Services (HHS) , Hospitals , Low-Income Issues , Medicare , Medicare Advantage , Medicare Part A , Medicare Part C , Notice and Comment , Pay Reductions , Provider Payments , Reaffirmation , Retroactive Application , SCOTUS , Substantive Rule , Vacated

Washington Healthcare Update February 2019 #4

Upcoming Hearings - Tuesday, Feb. 26, 2019 - Senate Finance Committee: “Drug Pricing in America: A Prescription for Change, Part II” - The second hearing in a series on drug pricing in the Senate Finance Committee...more

2/26/2019 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , HELP , Medicare Advantage , Medicare Part D , OMB , Pharmaceutical Industry , Prescription Drugs , Proposed Rules , Vaccinations

Washington Healthcare Update February 2019 #1

Coming Week’s Highlights: State of the Union scheduled for Feb. 5; House committees continue discussion on pre-existing conditions....more

2/5/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Congressional Budget Office , Department of Health and Human Services (HHS) , Drug Pricing , GAO , Medicare , Medicare Advantage , Medicare Part D , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs , Section 340B

Managed Care Quarterly Review: Issue 1

Tips for Managing Large Claims Disputes Part 1: Pre-Litigation Avoidance and Early Litigation Strategies - Large claims disputes brought by providers against payers are on the rise. Based on previous experience with dozens...more

9/25/2017 / 1332 Waiver , Affordable Care Act , Employee Retirement Income Security Act (ERISA) , False Claims Act (FCA) , Health Insurance Portability and Accountability Act (HIPAA) , Medicare Advantage , Medicare Advantage Organizations (MAOs) , Statistical Sampling

Stephanie Kennan

McGuireWoods LLP

Readers' Choice Awards

Popular Topics by This Author

Latest Posts › Medicare Advantage